ICEBERG study demonstrates improved outcomes of nasal spray for TRD
3rd November 2021 Uncategorised 0Back in 2019, esketamine was commercialised as Spravato, described as a “breakthrough” medication used to treat depression More: ICEBERG study demonstrates improved outcomes of nasal spray for TRD Source: News
read more